Incyte Corp | 76.01 / -0.64% |
Date/Time | 05/26 / 21:59 |
Chg. / Chg.(%) | -0.49 / -0.64% |
Bid | - |
Ask | - |
Open | 76.53 |
Previous Close | 76.50 |
High | 77.57 |
Low | 75.90 |
Volume [USD] | 1,418,531.97 |
Volume [Units] | 38,074 |
Price fixings | 172 |
ISIN | US45337C1027 |
Security | INCY |
Exchange | Cboe US |
Type | Stock |
Other Exchanges
Exchange | Last | Volume | |
---|---|---|---|
Hannover | 70.21 | ![]() |
0 |
Frankfurt | 70.3900 | ![]() |
0 |
München | 70.81 | ![]() |
0 |
Düsseldorf | 70.25 | ![]() |
0 |
Berlin | 70.60 | ![]() |
0 |
Lang & Schwa.. | 70.49 | ![]() |
|
Stuttgart | 70.250 | ![]() |
|
Quotrix | 70.4100 | ![]() |
|
gettex | 70.800 | ![]() |
|
NASDAQ | 76.0200 | ![]() |
845,955 |
Cboe US | 76.01 | ![]() |
38,074 |
IEX | 75.99 | ![]() |
35,606 |
London Domes.. | 76.88 | 343 | |
TradeGate | 71.920 | 279 | |
Mexico | 1,532.00 | ![]() |
85 |
News
- RECELL® System Vitiligo Clinical Trial Protocol to be Presented at the Global Vitiligo Foundation Annual Scientific Symposium
03/23/2022 / 21:01 - GlobeNewswire - STRATA Skin Sciences Names John Bagdasarian as Vice President of Professional Relations
03/14/2022 / 21:05 - GlobeNewswire - Actuate Therapeutics Announces First Patient Enrolled in Phase 2 Clinical Trial of Elraglusib Plus Retifanlimab as Investigational First Line Therapy for Patients With Advanced Pancreatic Cancer
03/01/2022 / 13:55 - GlobeNewswire - Merus Announces Financial Results for the Fourth Quarter and Full Year 2021 and Provides Business Update
02/28/2022 / 22:36 - GlobeNewswire - MacroGenics Provides Update on Corporate Progress and 2021 Financial Results
02/24/2022 / 22:01 - GlobeNewswire